SCHEMBL20205710

SCHEMBL20205710

CC1(C)c2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c3c(oc4ccccc43)c2-c2ccc3c(c21)C(C)(C)c1cc(-c2cc(-c4ccccc4)cc(-c4ccccc4)c2)c2oc4ccccc4c2c1-3

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 1/20 0.34
▸ CDC14A Q9UNH5 1/20 0.34
▸ ALOX5 P09917 2/20 0.31
▸ PLA2G2A P14555 1/20 0.31
▸ PLA2G4A P47712 1/20 0.31
▸ ALK Q9UM73 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ ALPI P09923 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ CASP3 P42574 1/20 0.30
▸ RECQL P46063 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ CASP7 P55210 1/20 0.30
▸ CASP6 P55212 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205384 0.97 CDC14B (0.36) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL23351578 0.96 CDC14B (0.34) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205314 0.95 CDC14B (0.36) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205324 0.94 CDC14B (0.37) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205315 0.94 CDC14B (0.38) CDC14BCDC14AALOX5ALKMEN1
SCHEMBL20205337 0.92 CDC14B (0.36) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205405 0.92 PLA2G2A (0.32) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205709 0.91 CDC14B (0.33) CDC14BCDC14AALKKDM4EMEN1
SCHEMBL20205381 0.91 CDC14B (0.39) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL23351982 0.91 CDC14B (0.36) CDC14BCDC14AALOX5PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND CDC14B 3977/4885CDC14A 4435/4885ALOX5 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback